Randomized comparison of group versus individual genetic education and counseling for familial breast and/or ovarian cancer

Journal of Clinical Oncology

Volumn 23, Issue 15, 2005, Pages 3455-3464

  Calzone, Kathleen A ^a   Prindiville, Sheila A ^a   Jourkiv, Oxana ^a   Jenkins, Jean ^a   DeCarvalho, Maria ^a   Wallerstedt, Dawn B ^a   Liewehr, David J ^a   Steinberg, Seth M ^a   Soballe, Peter W ^a   Lipkowitz, Stan ^a   Klein, Pamela ^a   Kirsch, Ilan R ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISTRESS SYNDROME; FAMILIAL CANCER; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OVARY CANCER; PATIENT EDUCATION; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; ATTITUDE TO HEALTH; BREAST TUMOR; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; GROUP THERAPY; METHODOLOGY; MIDDLE AGED; MUTATION; OVARY TUMOR; PATIENT COMPLIANCE; RISK ASSESSMENT; SOCIOECONOMICS; TUMOR SUPPRESSOR GENE;

ADULT; AGED; ATTITUDE TO HEALTH; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; PATIENT COMPLIANCE; PATIENT EDUCATION; PSYCHOTHERAPY, GROUP; RISK ASSESSMENT; SOCIOECONOMIC FACTORS;

EID: 20644455962     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.04.050     Document Type: Article

References (37)

1. Jemal A, Tiwari RC, Murray T, et al: Cancer statistics, 2004. CA Cancer J Clin 54:8-29, 2004
2. Wooster R, Bignell G, Lancaster J, et al: Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792, 1995
3. Miki Y, Swensen J, Shattuck-Eidens D, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71, 1994
4. Tavtigian SV, Simard J, Rommens J, et al: The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 12: 333-337, 1996
5. Burke W, Daly M, Garber J, et al: Recommendations for follow-up care of individuals with an inherited predisposition to cancer: II. BRCA1 and BRCA2-Cancer Genetics Studies Consortium. JAMA 277:997-1003, 1997
6. Gray S, Olopade OI: Direct-to-consumer marketing of genetic tests for cancer: Buyer beware. J Clin Oncol 21:3191-3193, 2003
7. Petersen GM: Genetic testing. Hematol Oncol Clin North Am 14:939-952, 2000
8. Cummings S: The genetic testing process: How much counseling is needed? J Clin Oncol 18:60s-64s, 2000 (suppl)
9. Kessler S: Psychological aspects of genetic counseling: IX. Teaching and counseling. J Genet Couns 6:287-295, 1997
10. Bennet RL, Hampel HL, Mandell JB, et al: Genetic counselors: Translating genomic science into clinical practice. J Clin Invest 112:1274-1279, 2003
11. Lerman C, Biesecker B, Benkendorf JL, et al: Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. J Natl Cancer Inst 89:148-157, 1997
12. Skinner CS, Schildkraut JM, Berry D, et al: Pre-counseling education materials for BRCA testing: Does tailoring make a difference? Genetic Testing 6:93-105, 2002
13. Cull A, Miller H, Porterfield T, et al: The use of videotaped information in cancer genetic counseling: A randomized evaluation study. Br J Cancer 77:830-837, 1998
14. Green MJ, Biesecker BB, McInerney AM, et al: An interactive computer program can effectively educate patients about genetic testing for breast cancer susceptibility. Am J Med Genet 103:16-23, 2001
15. Green MJ, McInerney AM, Biesecker BB, et al: Education about genetic testing for breast cancer susceptibility: Patient preferences for a computer program or genetic counselor. Am J Med Genet 103:24-31, 2001
16. Wilson S: Individual versus group education: Is one better? Patient Educ Couns 32:S67-S75, 1997 (suppl)
17. Barlow JJ, Barefoot J: Group education for people with arthritis. Patient Educ Couns 27:257-267, 1996
18. Sarkadi A, Rosenqvist U: Study circles at the pharmacy: A new model for diabetes education in groups. Patient Educ Couns 37:89-96, 1999
19. Kruseman M, Stoll BE, Stalder H: Interactive group education for refugees from the former Yugoslavia to reduce their oil consumption. Patient Educ Couns 49:171-176, 2003
20. Lepore S, Helgeson V, Eton D, et al: Improving quality of life in men with prostate cancer: A randomized controlled trial of group education interventions. Health Psychol 22:443-452, 2003
21. Snyder LA, Wallerstedt DB, Lahl LL, et al: Development of the breast cancer education and risk assessment program. Oncol Nurs Forum 30:803-808, 2003
22. McKinnon W, Baty B, Bennett R, et al: Predisposition genetic testing for late-onset disorders in adults: A position paper of the National Society of Genetic Counselors. JAMA 278:1217-1220, 1997
23. Geer KP, Ropka ME, Cohn WF, et al: Factors influencing patients' decisions to decline cancer genetic counseling services. J Genet Couns 10:25-40, 2001
24. MacDonald DJ, Choi J, Ferrell B, et al: Concerns of women presenting to a comprehensive cancer centre for genetic cancer risk assessment. J Med Genet 39:526-530, 2002
25. Biesecker BB, Ishibe N, Hadley DW, et al: Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. Am J Med Genet 93:257-263, 2000
26. International Society of Nurses in Genetics I: Statement on the Scope and Standards of Genetics Clinical Nursing Practice. Washington, DC, American Nurses Association, 1998
27. Hughes C, Gomez-Caminero A, Benkendorf J, et al: Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ Couns 32:51-62, 1997
28. Bluman LG, Rimer BK, Berry DA, et al: Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. J Clin Oncol 17:1040-1046, 1999
29. Horowitz M, Wilner N, Alvarez W: Impact of Event Scale: A measure of subjective stress. Psychosom Med 41:209-218, 1979
30. Zilberg NJ, Weiss DS, Horowitz MJ: Impact of event scale: A cross-validation study and some empirical evidence supporting a conceptual model of stress response syndromes. J Consult Clin Psychol 50:407-414, 1982
31. Hollander M, Wolfe DA: Non-Parametric Statistical Methods (ed 2). New York, NY, John Wiley and Sons, Inc. 1999, pp 189-269
32. Agresti A: Categorical Data Analysis. New York, NY, John Wiley and Sons, Inc, 1990, pp 79-129
33. Lees-Haley P, Price JR, Williams CW, et al: Use of the Impact of Events Scale in the assessment of emotional distress and PTSD may produce misleading results. J Forensic Neuropsychol 2:45-52, 2001
34. Coyne JC, Kruus L, Racioppo M, et al: What do ratings of cancer-specific distress mean among women at high risk of breast and ovarian cancer? Am J Med Genet 116A:222-228, 2003
35. Guttmacher AE, Collins FS: Welcome to the genomic era. N Engl J Med 349:996-998, 2003
36. Goodwin PJ, Leszcz M, Quirt G, et al: Lessons learned from enrollment in the BEST study: A multicenter, randomized trial of group psychosocial support in metastatic breast cancer. J Clin Epidemiol 53:47-55, 2000
37. Rimer BK, Schildkraut JM, Lerman C, et al: Participation in a women's breast cancer risk trial: Who participates? Who declines? Cancer 77:2348-2355, 1996